Yazar "Cüre, Osman" için listeleme
-
Angioedema in a patient with ankylosing spondylitis treated with etanercept
Cüre, Osman; İlkkılıç, Kadir (Türkiye Klinikleri Yayınevi, 2023)Ankylosing spondylitis (AS) is a chronic inflammatory disease of unknown pathogenesis. Nonsteroidal antiinflammatory and biologic drugs are used in its treatment. A 38 year old male patient diagnosed with AS was admitted ... -
Another side of lupus: A case report of lupus presenting with cutaneous vasculitis
Cüre, Osman; İlkkılıç, Kadir (Wiley, 2023)Systemic lupus erythematosus (SLE) is a systemic autoimmune complex disease that affects any organ, characterized by immune complex formation and autoantibody production. Lupus vasculitis begins at a young age. These ... -
Cardiovascular risk in patients with ankylosing spondylitis
Klisic, Aleksandra; Kotur-Stevuljevic, Jelena; Cüre, Osman; Kızılkaya, Bayram; Çeliker, Fatma Beyazal; Er, Hüseyin; Mercantepe, Filiz (MDPI, 2024)Objectives: Ankylosing spondylitis (AS) is an autoinflammatory, chronic disease. Patients with AS are at increased risk of cardiovascular disease (CVD). The link between AS and subclinical atherosclerosis is multifactorial ... -
The development of ankylosing spondylitis in a patient with familial hemophilia
Cüre, Osman; İlkkılıç, Kadir (Wiley, 2023)Hemophilia is a rare inherited disease which causes bleeding due to Factor VIII or Factor IX deficiency. It is usually X-linked recessive and typically affects males. Arthropathy occurs as a result of cartilage damage and ... -
The effect of anti-tumor necrosis factor therapy on the plasma atherogenic index in rheumatic diseases
Cüre, Osman; Kızılkaya, Bayram; Çiftel, Serpil; Mercantepe, Filiz (Mary Ann Liebert Inc., 2024)Background: The risk of atherosclerosis is increased in individuals with rheumatological disease. The objective of this study is to examine the heightened susceptibility to atherosclerosis in persons afflicted with ... -
Effect of fibromyalgia on demographic, biochemical, metabolic and inflammatory profiles: a single-centre retrospective study
Cüre, Osman; Kızılkaya, Bayram; Çiftel, Serpil; Klisic, Aleksandra; Çiftel, Enver; Mercantepe, Filiz (Pisa, Italy : Pacini editore, 2024)Objectives: The objective of this study is to ascertain the disparities in demographic features and biochemical profiles between individuals diagnosed with fibromyalgia (FM) and a control group of healthy individuals. Methods: ... -
An example of a comprehensive approach to increase the access to evidence-based tobacco cessation support for smokers with rheumatic diseases
Cüre, Osman; Karadoğan, Dilek; Telatar, Tahsin Gökhan; İlkkılıç, Kadir (European Publishing, 2023)INTRODUCTION For a comprehensive approach to adult smoking cessation, contributions by all physicians are more relevant than individual efforts. This study is an example of a collaboration that aims to increase access to ... -
An example of comprehensive approach to tobacco cessation: Collaboration with Rheumatology Clinic
Cüre, Osman; Karadoğan, Dilek; Telatar, Tahsin Gökhan; İlkkılıç, Kadir (European Respiratory, 2023)Background and aim: For a comprehensive approach to adult smoking cessation, all physicians' contribution is much more relevant than the individual efforts. This study aims to evaluate the effectiveness of brief cessation ... -
Factors affecting mortality in COVID-19 patients treated with intravenous immunoglobulin
İlkkılıç, Kadir; Cüre, Osman; Beyazal Polat, Hatice; Sen, Bayram; Aydın, Esra; Avcı, Uğur; Tüfekçi, Damla (İnönü Üniversitesi Tıp Fakültesi, 2023)Aim: Intravenous immunoglobulin (IVIG), used as an option in the treatment of severe Coronavirus disease 2019 (COVID-19), has been shown to have effects on the suppression of the hyperinflammatory state through immunomodulatory ... -
Factors affecting mortality in COVID-19 patients treated with tocilizumab
Cüre, Osman; İlkkılıç, Kadir; Şen, Bayram; Arpa, Medeni; Aydın, Esra; Avcı, Uğur; Tüfekçi, Damla; Polat, Hatice Beyazal; Kızılkaya, Bayram (Yuzuncu Yil Universitesi Tip Fakultesi, 2024)The aim of our study was to evaluate the risk factors associated with mortality in COVID-19 patients. During March 2020 to March 2022, 136 patients who were treated with tocilizumab in the service and intensive care unit ... -
Hepatitis B reactivation risk and physician awareness in rheumatological patients receiving anti-tumor necrosis factor-α treatment
Cüre, Osman; Kızılkaya, Bayram; Durak, Serdar; İlkkılıç, Kadir (Assoc Medica Brasileira, 2024)OBJECTIVE: We aimed to evaluate the risk of hepatitis B virus reactivation in rheumatic patients using anti-tumor necrosis factor-alpha drugs and the awareness of physicians about hepatitis B virus reactivation. METHODS: ... -
Independent relationship between ankylosing spondylitis and presystolic wave detected on echocardiography
Ergül, Elif; Özyıldız, Ali Gökhan; Barutçu, Gökhan; Cüre, Osman; Durak, Hüseyin; Özyıldız, Afag; Çetin, Mustafa (Wolters Kluwer Medknow Publications, 2024)Objective: Ankylosing spondylitis (AS) is a persistent inflammatory disease affecting the axial skeleton which may lead to cardiovascular involvement. We examined the relationship between the presystolic wave (PW), which ... -
Independent relationship between uveitis and increased left atrial volume index in ankylosing spondylitis patients
Cüre, Osman; Ergül, Elif; Çetin, Mustafa; İlkkılıç, Kadir; Kızılkaya, Bayram; Durak, Serdar (İnönü Üniversitesi Tıp Fakültesi, 2024)Aim: The aim of this study was to evaluate the relationship between uveitis and left atrial volume index (LAVI) in patients with ankylosing spondylitis (AS). Materials and Methods: Demographic, clinical, echocardiographic ... -
Inflammatory polyarthritis induced by nivolumab treatment in a patient with malignant melanoma: A case report
Cüre, Osman; İlkkılıç, Kadir; Altuner, Mehmet Şakir (İnönü Üniversitesi Tıp Fakültesi, 2023)Nivolumab is a monoclonal antibody that inhibits the programmed death ligand 1 from binding with PD-1 and restricts T-cell inactivation against cancer cells. After the introduction of nivolumab, in addition to its known ... -
Management of patients with connective tissue disease-associated interstitial lung diseases during the COVID-19 pandemic
Gürkan, Canan Gündüz; Karadoğan, Dilek; Ufuk, Furkan; Cüre, Osman; Altınışık, Göksel (AVES, 2021)The novel coronavirus disease (COVID-19) is similar to connective tissue disease-associated interstitial lung diseases (CTD-ILD) in many aspects. However, patients with CTD-ILD have required particular attention during the ... -
Occupational risks and safety precautions for COVID-19 in workers with rheumatic diseases
Sandal, Abdulsamet; Karadoğan, Dilek; Töreyin, Zehra Nur; Cüre, Osman; Akgün, Metin (Lippincott Williams & Wilkins, 2020)Coronavirus disease 2019 (COVID-19) has spread worldwide rapidly and was declared a pandemic on March 11, 2020, by the World Health Organization. -
The role of platelet to lymphocyte ratio (plr) in predicting early treatment response in diffuse large b cell lymphoma
İlkkılıç, Kadir; Şen, Bayram; Cüre, Osman (Springer, 2024)Background: Systemic inflammatory response in diffuse large B-cell lymphoma (DLBCL) is closely related to disease prognosis. Our aim is to determine the role of pretreatment platelet-to-lymphocyte ratio (PLR) in predicting ... -
Secukinumab may be an effective treatment option for axial spondyloarthritis and psoriatic arthritis patients with a history of malignancy: multicenter real-life experience from Turkey
Ocak, Tuğba; Yağız, Burcu; Ocak, Birol; Yoğurtçu, Özge; Başıbüyük, Fatma; Tezcan, Dilek; Ermurat, Selime; İnanç, Elif; Yamancan, Gülşah; Albayrak, Fatih; Sağır, Rabia Pişkin; Bayındır Akbaş, Ayşe Nur; Cüre, Osman; Coşkun, Belkıs Nihan; Yolbaş, Servet; Karasu, Uğur; Kısacık, Bünyamin; Koca, Süleyman Serdar; Sarı, İsmail; Akar, Servet; Pehlivan, Yavuz (MDPI, 2024)Background: Secukinumab is a monoclonal antibody against interleukin 17 approved for patients with axial spondyloarthritis (axSpA), psoriatic arthritis (PsA), and psoriasis. Treating axSpA and PsA patients with a history ...
